Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224952 · ClinicalTrials.gov registry record
Pathogenesis of Adverse Drug Reactions
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 274
- Enrollment target
NCT00224952: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00224952 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 274 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00224952 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 274 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the individual metabolic profiles of pediatric patients receiving carbamazepine or valproate therapy, in an attempt to determine identities of the reactive metabolites or, alternatively, the identities of those metabolites that serve as potential precursors to reactive species.
Primary Outcome
1\. To examine the individual metabolic profiles of pediatric patients receiving carbamazepine or valproate therapy, in an attempt to determine the identities of the reactive metabolites or, alternatively, the identities of those metabolites that serve as potential precursors to reactive species (e.g., through conjugation with detoxifying compounds such as glutathione).
Interventions
- OTHER No intervention; Urine Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2002-07 |
| Est. Completion | 2010-03 |
What the finished NCT00224952 record still lists
NCT00224952 is an observational study that tracks outcomes without assigning an intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention; Urine Collection is the first listed.
NCT00224952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00224952 about?
NCT00224952 is a clinical study titled "Pathogenesis of Adverse Drug Reactions". The purpose of the study is to examine the individual metabolic profiles of pediatric patients receiving carbamazepine or valproate therapy, in an attempt to determine identities of the reactive metabolites or, alternatively, the identities of those metabolites that serve as potential precursors to ...
What is the current status of trial NCT00224952?
This trial is currently completed. The enrollment target is 274 participants. The study started on 2002-07. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00224952?
The interventions under investigation include: No intervention; Urine Collection (OTHER).
Who is sponsoring clinical trial NCT00224952?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia